713
Participants
Start Date
July 2, 2018
Primary Completion Date
February 20, 2020
Study Completion Date
Lenvatinib
Lenvatinib capsule
Eisai trial site 1, Osaka
Eisai trial site 2, Tokyo
Eisai Inc.
INDUSTRY